V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270017826 | 270008282 | 0 | 100 | Curative (C) | 2015-03-04 | 2015-05-08 | COPP + Dacarbazine | N | null | 270012357 | COPP + DACARBAZINE |
| 270017827 | 270008287 | null | 47.9 | Curative (C) | 2016-11-29 | 2016-12-04 | CETUXIMAB | N | null | 270012371 | CETUXIMAB |
| 270017828 | 270008289 | null | 57 | Neo-adjuvant (N) | 2018-01-26 | 2018-04-17 | HD EuroNet-PHL-C1 COPDAC | Y | N | 270012379 | TRIAL |
| 270017829 | 270008291 | 0 | 143.7 | Curative (C) | 2014-10-10 | 2014-10-10 | COPP + Dacarbazine | N | N | 270012381 | COPP + DACARBAZINE |
| 270017830 | 270008294 | null | 78.4 | Curative (C) | 2018-03-06 | 2018-03-06 | COPP + Dacarbazine | N | N | 270012391 | COPP + DACARBAZINE |
| 270017831 | 270008300 | 1.66 | 66.2 | Curative (C) | 2017-10-15 | 2017-10-17 | HD EuroNet-PHL-C1 COPDAC | Y | N | 270012423 | TRIAL |
| 270017832 | 270013939 | 1.68 | 77 | Palliative (P) | 2015-12-12 | 2015-12-12 | CETUXIMAB | N | N | 270012431 | CETUXIMAB |
| 270017833 | 270008306 | 1.78 | 63.7 | Curative (C) | 2019-02-16 | 2019-05-04 | Cetuximab 7 day (>Cycle 2) | 2 | N | 270012438 | CETUXIMAB |
| 270017834 | 270008313 | 0 | 68.7 | Curative (C) | 2015-03-11 | 2015-03-12 | HD EuroNet-PHL-C1 COPDAC | 2 | N | 270012461 | TRIAL |
| 270017835 | 270008317 | 1.61 | 57.65 | Curative (C) | 2016-05-29 | 2016-08-04 | COPP + Dacarbazine | N | N | 270012463 | COPP + DACARBAZINE |
| 270017836 | 270008328 | 1.64 | 58.5 | Palliative (P) | 2014-07-30 | 2014-08-05 | Trial Unspecified | N | null | 270012479 | TRIAL |
| 270017837 | 270008332 | 0 | 93.8 | Palliative (P) | 2015-03-29 | 2015-07-25 | HD EuroNet-PHL-C1 Relapsed IEP | Y | N | 270012501 | TRIAL |
| 270017838 | 270008343 | 0 | 73.9 | Adjuvant (A) | 2014-01-31 | 2014-04-02 | COPP + Dacarbazine | 02 | N | 270012525 | COPP + DACARBAZINE |
| 270017839 | 270008350 | 1.71 | 63.3 | Disease modification (D) | 2016-05-16 | 2016-05-18 | BEACOPP | 02 | null | 270012536 | BEACOPP |
| 270017840 | 270008352 | 1.61 | 57.95 | Curative (C) | 2016-08-16 | 2016-09-20 | HD EuroNet-PHL-C1 COPDAC | N | N | 270012539 | TRIAL |
| 270017841 | 270008354 | 1.72 | 73.9 | Curative (C) | 2017-02-05 | 2017-02-05 | COPP + Dacarbazine | N | null | 270012545 | COPP + DACARBAZINE |
| 270017842 | 270008355 | 1.62 | 57.4 | Curative (C) | 2015-07-11 | 2015-08-01 | CETUXIMAB | 02 | N | 270012548 | CETUXIMAB |
| 270017843 | 270008360 | null | null | null | 2017-04-22 | 2017-04-22 | COPP + Dacarbazine | 02 | N | 270012569 | COPP + DACARBAZINE |
| 270017844 | 270008364 | 1.64 | 76.1 | Curative (C) | 2013-12-09 | 2014-02-05 | BEACOPP | N | N | 270012579 | BEACOPP |
| 270017845 | 270016644 | 1.69 | 127 | Palliative (P) | 2016-05-31 | 2016-06-26 | Trial Unspecified | N | N | 270012583 | TRIAL |
| 270017846 | 270020137 | 1.72 | 87.7 | Curative (C) | 2016-07-02 | 2017-10-30 | Cetuximab 7 day (Cycle 1) | N | N | 270012592 | CETUXIMAB |
| 270017847 | 270008374 | 1.67 | 101.2 | Curative (C) | 2013-01-24 | 2013-11-18 | CETUXIMAB | 2 | N | 270012597 | CETUXIMAB |
| 270017848 | 270008376 | 1.67 | 118 | Curative (C) | null | 2017-10-15 | Cetuximab 14 day | N | N | 270012598 | CETUXIMAB |
| 270017849 | 270008379 | null | null | Curative (C) | 2017-03-04 | 2017-03-08 | HD EuroNet-PHL-C1 COPDAC | N | N | 270012612 | TRIAL |
| 270017850 | 270008384 | 1.67 | 69.4 | Curative (C) | 2014-12-10 | 2014-12-10 | BEACOPP-14 | null | N | 270012644 | BEACOPP |
| 270017851 | 270008389 | 1.63 | 63.3 | Curative (C) | 2015-12-16 | 2015-12-23 | LUX TRIAL | 2 | N | 270012656 | TRIAL |
| 270017852 | 270013975 | null | 102.9 | Curative (C) | 2017-10-03 | 2017-12-06 | COPP + Dacarbazine | N | null | 270012660 | COPP + DACARBAZINE |
| 270017853 | 270008402 | null | 52 | null | 2017-04-15 | 2017-10-09 | CETUXIMAB | N | null | 270012679 | CETUXIMAB |
| 270017854 | 270019094 | 1.81 | 43.1 | Curative (C) | 2017-10-30 | 2018-01-01 | BEACOPP | N | null | 270012686 | BEACOPP |
| 270017855 | 270008408 | 1.59 | 37.1 | Curative (C) | 2017-02-25 | 2017-03-12 | Escalated BEACOPP | N | N | 270012713 | BEACOPP |
| 270017856 | 270008413 | null | 72 | Curative (C) | null | 2018-07-19 | HD EuroNet-PHL-C1 COPDAC | Y | N | 270012719 | TRIAL |
| 270017857 | 270013983 | 1.74 | 40 | Curative (C) | 2016-08-15 | 2016-08-17 | Escalated BEACOPP | N | N | 270012720 | BEACOPP |
| 270017858 | 270008420 | null | 95.6 | Curative (C) | 2016-03-16 | 2016-03-31 | Cetuximab 14 day | N | N | 270012723 | CETUXIMAB |
| 270017859 | 270008423 | 1.67 | 119.87 | Curative (C) | 2016-12-25 | 2017-02-02 | Cetuximab 14 day | null | N | 270012726 | CETUXIMAB |
| 270017860 | 270008427 | 0 | 25.1 | Curative (C) | 2013-12-12 | 2013-12-29 | COPP + Dacarbazine | N | N | 270012737 | COPP + DACARBAZINE |
| 270017861 | 270008430 | null | null | Curative (C) | 2015-12-08 | 2016-02-08 | Escalated BEACOPP | N | N | 270012740 | BEACOPP |
| 270017862 | 270008435 | 0 | 73.5 | Curative (C) | 2014-01-07 | 2014-03-15 | COPP + Dacarbazine | N | Y | 270012753 | COPP + DACARBAZINE |
| 270017863 | 270013989 | null | 87.3 | Curative (C) | 2013-12-08 | 2013-12-15 | BEACOPP | 99 | N | 270012753 | BEACOPP |
| 270017864 | 270008442 | null | 27.8 | Curative (C) | 2015-04-04 | 2015-05-30 | CETUXIMAB | 99 | null | 270012758 | CETUXIMAB |
| 270017865 | 270016666 | 1.8 | null | null | 2016-05-10 | 2016-07-19 | Escalated BEACOPP | N | N | 270012818 | BEACOPP |
| 270017866 | 270008457 | 1.65 | 31.2 | Curative (C) | 2017-04-05 | 2017-04-29 | Cetuximab 7 day (Cycle 1) | N | null | 270012821 | CETUXIMAB |
| 270017867 | 270008463 | 1.57 | 34.8 | Neo-adjuvant (N) | null | 2014-12-25 | Cetuximab 14 day | N | null | 270012830 | CETUXIMAB |
| 270017868 | 270008463 | 1.65 | 78 | null | 2016-01-12 | 2016-01-14 | BEACOPP-14 | N | N | 270012830 | BEACOPP |
| 270017869 | 270008468 | null | 87 | null | 2014-06-18 | 2014-06-19 | COPP + Dacarbazine | 02 | N | 270012834 | COPP + DACARBAZINE |
| 270017870 | 270008470 | null | null | Curative (C) | null | 2015-05-28 | Escalated BEACOPP | 2 | N | 270012843 | BEACOPP |
| 270017871 | 270008481 | 1.76 | 77.25 | Curative (C) | 2017-01-15 | 2017-03-19 | HD EuroNet-PHL-C1 COPDAC | N | null | 270012897 | TRIAL |
| 270017872 | 270008483 | 1.58 | 66.5 | Curative (C) | null | 2017-10-01 | Cetuximab 14 day | 99 | N | 270012904 | CETUXIMAB |
| 270017873 | 270008486 | 1.61 | 49 | Curative (C) | 2018-04-04 | 2018-06-13 | BEACOPP | 2 | null | 270012909 | BEACOPP |
| 270017874 | 270008487 | null | 78.9 | Curative (C) | 2016-04-08 | 2016-06-04 | COPP + Dacarbazine | N | N | 270012909 | COPP + DACARBAZINE |
| 270017875 | 270008488 | 0 | 55.2 | Curative (C) | 2016-04-18 | 2016-06-30 | COPP + Dacarbazine | N | N | 270012920 | COPP + DACARBAZINE |